Navigation Links
Amgen Announces 2013 Second Quarter Dividend
Date:3/6/2013

THOUSAND OAKS, Calif., March 6, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced that its Board of Directors today declared a $0.47 per share dividend for the second quarter of 2013. The dividend will be paid on June 7, 2013, to all stockholders of record as of the close of business on May 16, 2013. 

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit www.amgen.com. Follow us on www.twitter.com/amgen.

Forward-Looking Statements
This news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in our Form 10-K for the year ended Dec. 31, 2012, and in our periodic reports on Form 10-Q and Form 8-K. Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. 

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. The Company's results may be affected by
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy
2. Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate® (Romiplostim)
3. Amgen Announces 2012 First Quarter Dividend
4. Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012
5. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
6. Amgen Announces Webcast of 2011 Fourth Quarter and Full Year Financial Results
7. Amgen to Acquire Micromet
8. Amgen to Present at the Leerink Swann Global Healthcare Conference
9. Amgen Announces 2012 Third Quarter Dividend
10. Amgen Names Ray Jordan Senior Vice President, Corporate Affairs
11. Amgen To Present At The 24th Annual Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... “Rapid technological advances will spread ... increasing unemployment, depressing American consumer spending and further ... Catch 22—we need automated manufacturing if we are ... says economist and corporate relocation expert Dr. Ron ... Pro-Business States for 2014, co-published with the American ...
(Date:7/31/2014)... Fla. (PRWEB) July 31, 2014 The Kidney ... distribution of its monthly news magazine, Kidney Cancer News. ... a presence on a website maintained by an international news ... an immediate increase in viewers.” , This month’s program highlights ... kidney tumors analyzed in a recent study. Kidney Cancer ...
(Date:7/30/2014)... 30, 2014 Regulus Therapeutics Inc . ... the discovery and development of innovative medicines targeting microRNAs, ... highlights for the quarter ended June 30, 2014 on ... close. Regulus will host a conference ... 5:00 pm Eastern Daylight Time to discuss its second ...
(Date:7/30/2014)...  Decision Resources Group finds that the majority ... the United States believe that ... be the level of savings achievable by their ... cost to patients. Payers plan to leverage preferential ... expectations in order to encourage physician prescribing of ...
Breaking Biology Technology:ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 2ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 4Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 3
... N.C., May 11, 2011 Micell Technologies, Inc. ... presented at the EuroPCR conference in Paris, France ... "MiStent DES: A Novel Third Generation DES with ... The MiStent Drug-Eluting Coronary Stent System ("MiStent DES") ...
... 2011 Reportlinker.com announces that a new market ... Healthcare Information Technology ... REPORT HIGHLIGHTS * BCC estimates ... technologies covered in this report at more than ...
... Research being presented at Digestive Disease Week ... benefits for qualifying patients undergoing bariatric surgery, the ... considered when determining whether the surgery is appropriate ... of physicians and researchers in the field of ...
Cached Biology Technology:Micell Technologies Reports Preclinical Data for MiStent™ Drug-Eluting Coronary Stent to be Presented at EuroPCR 2Micell Technologies Reports Preclinical Data for MiStent™ Drug-Eluting Coronary Stent to be Presented at EuroPCR 3Reportlinker Adds Healthcare Information Technology 2Reportlinker Adds Healthcare Information Technology 3Reportlinker Adds Healthcare Information Technology 4Reportlinker Adds Healthcare Information Technology 5Reportlinker Adds Healthcare Information Technology 6Reportlinker Adds Healthcare Information Technology 7Reportlinker Adds Healthcare Information Technology 8Reportlinker Adds Healthcare Information Technology 9Reportlinker Adds Healthcare Information Technology 10Reportlinker Adds Healthcare Information Technology 11New approaches, technological advances offer promise for obesity treatment 2
(Date:7/31/2014)... is available in German . ... up gases similar to a sponge that soaks up ... storing hydrogen or greenhouse gases. However, loading of many ... of Technology (KIT) now report in Nature Communications ... the MOF surface. This can be prevented by water-free ...
(Date:7/31/2014)... July 31, 2014 -- Do people make a rational ... raise them that way? Is it a matter of ... and a colleague from Rice University say that neither ... people lean left while others lean right. , A ... deep-seated psychology are at the core of political differences, ...
(Date:7/31/2014)... first discovered the photovoltaic effect in 1839, humankind has ... sunlight for its own purposes. In a new research ... FASEB Journal , scientists may have ... sunlight by focusing on a naturally occurring combination of ... conservationor persistence over time and across speciessuggests that this ...
Breaking Biology News(10 mins):Free pores for molecule transport 2Scientists find growing consensus: Political attitudes derive from body and mind 2Scientists shine bright new light on how living things capture energy from the sun 2
... the American Association of University Women (AAUW), will be ... Meeting of the Entomological Society of America (ESA). Her ... on Sunday, November 13, 2011. An important subtheme ... area where ESA President Delfosse feels there is an ...
... Researchers at Hewlett Packard and the University of ... physical and chemical properties of an electronic device that ... Memristors, short for memory resistors, are a newly ... have inspired experts to seek ways of mimicking the ...
... Gene expression is the process of converting the ... product such as a protein or any of several ... gene programs regulated by different physiological processes throughout the ... specialized cell. But a new study by researchers from ...
Cached Biology News:Christianne Corbett to speak at Entomology 2011 2'Computer synapse' analyzed at the nanoscale 2Plasticity of hormonal response permits rapid gene expression reprogramming 2
... industry's first siRNA sequence design software in ... these tools consistent with new experimental strategies ... of RNAi. With the introduction of ... tools, OligoEngine is pleased to offer the ...
... perform many sophisticated DNA analysis and protein analysis ... just another sequence analysis product. Imagine having the ... to be performed each time you have a ... which specify exactly how your output will look ...
... Western Blot Signal Enhancer does for enzyme-/substrate-based blotting ... it increases the signal up to 10-fold (or ... ,The Western Blot Signal Enhancer membrane treatment ... added to your current Western blotting protocol. ...
These stopping screens are for the biolistic PDS-1000 He and Hepta systems. Supplied as 500 screens....
Biology Products: